Nifty

14433.70

Sensex

49034.67

-161.90 (-1.11%)
-549.49 (-1.11%)

Nifty
Sensex

:
:

14433.70
49034.67

-161.90 (-1.11%)
-549.49 (-1.11%)

Biocon Ltd.

Pharmaceuticals & Drugs - Global

Rating :

63/99 (View)

BSE: 532523 | NSE: BIOCON

Watchlist

NSE BSE

457.05

-9.40 (-2.02%)

15-Jan-2021 | 4:01PM

Day's Open
Day's High
Day's Low
Previous Close

466.50
466.60
455.00
466.45

Volume
Traded Value (lacs)
52 Week High
52 Week Low

2795557
12777.09
487.75
235.55

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

54,810.00
85.05
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

56,472.80
N/A
7.78

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.43
13.72
15.58

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-5.97
10.36
8.68

PAT CAGR (%)

10 Years
5 Years
3 Years

7.78
8.01
30.32

P:E (Median)

8 Years
5 Years
3 Years

24.78
41.63
55.66

P:BV (Average)

8 Years
5 Years
3 Years

4.41
5.50
6.38

EV:EBITDA (Average)

8 Years
5 Years
3 Years

19.49
24.56
28.22

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 560.00 523.90 6.89% 520.70 480.80 8.30% 482.40 462.80 4.24% 501.30 443.40 13.06%
Expenses 472.10 434.00 8.78% 404.00 407.40 -0.83% 439.00 420.40 4.42% 424.30 403.40 5.18%
EBITDA 87.90 89.90 -2.22% 116.70 73.40 58.99% 43.40 42.40 2.36% 77.00 40.00 92.50%
EBIDTM 15.70% 17.16% 7.67% 7.67% 9.00% 9.16% 15.36% 9.02%
Other Income 38.40 60.30 -36.32% 36.00 25.30 42.29% 67.20 13.00 416.92% 51.20 35.10 45.87%
Interest 0.10 0.40 -75.00% 0.10 0.50 -80.00% 0.20 0.60 -66.67% 0.10 0.80 -87.50%
Depreciation 26.40 24.10 9.54% 25.70 24.00 7.08% 24.60 23.40 5.13% 25.30 23.40 8.12%
PBT 99.80 125.70 -20.60% 126.90 156.20 -18.76% 108.50 31.40 245.54% 157.80 50.90 210.02%
Tax 4.80 25.70 -81.32% 42.10 34.20 23.10% 14.90 0.30 4,866.67% 37.10 6.60 462.12%
PAT 95.00 100.00 -5.00% 84.80 122.00 -30.49% 93.60 31.10 200.96% 120.70 44.30 172.46%
PATM 16.96% 19.09% -1.60% -1.60% 19.40% 6.72% 24.08% 9.99%
EPS 0.79 0.83 -4.82% 0.71 1.02 -30.39% 0.78 0.26 200.00% 1.01 0.37 172.97%

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 1,744.80 1,567.30 11.33% 1,671.30 1,458.90 14.56% 1,581.00 1,528.80 3.41% 1,748.10 1,540.80 13.45%
Expenses 1,353.40 1,164.50 16.22% 1,258.00 1,021.40 23.16% 1,262.40 1,125.80 12.13% 1,303.90 1,160.10 12.40%
EBITDA 391.40 402.80 -2.83% 413.30 437.50 -5.53% 318.60 403.00 -20.94% 444.20 380.70 16.68%
EBIDTM 22.43% 25.70% 24.73% 29.99% 14.01% 14.01% 25.41% 24.71%
Other Income 15.50 38.40 -59.64% 18.30 24.10 -24.07% 63.10 28.20 123.76% 35.80 25.60 39.84%
Interest 6.50 13.80 -52.90% 12.50 16.60 -24.70% 16.80 15.90 5.66% 17.70 18.60 -4.84%
Depreciation 177.70 131.60 35.03% 166.80 124.20 34.30% 152.40 119.80 27.21% 144.00 116.70 23.39%
PBT 222.70 363.30 -38.70% 252.30 320.80 -21.35% 212.50 295.50 -28.09% 318.30 276.80 14.99%
Tax 22.30 100.10 -77.72% 80.90 85.20 -5.05% 45.00 40.90 10.02% 84.80 46.10 83.95%
PAT 200.40 263.20 -23.86% 171.40 235.60 -27.25% 167.50 254.60 -34.21% 233.50 230.70 1.21%
PATM 11.49% 16.79% 10.26% 16.15% 7.11% 7.11% 13.36% 14.97%
EPS 1.41 1.80 -21.67% 1.25 1.72 -27.33% 28.29 28.29 0.00% 1.69 1.81 -6.63%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 2,064.40 2,184.20 2,893.30 2,419.20 2,587.90 2,301.80 2,241.60 2,202.50 1,938.00 1,555.80 1,561.10 Net Sales Growth 8.03% -24.51% 19.60% -6.52% 12.43% 2.69% 1.78% 13.65% 24.57% -0.34% Cost Of Goods Sold 919.17 827.70 788.50 1,049.40 1,035.20 987.50 947.10 950.90 862.50 704.40 622.30 Gross Profit 1,145.23 1,356.50 2,104.80 1,369.80 1,552.70 1,314.30 1,294.50 1,251.60 1,075.50 851.40 938.80 GP Margin 55.48% 62.11% 72.75% 56.62% 60.00% 57.10% 57.75% 56.83% 55.50% 54.72% 60.14% Total Expenditure 1,739.40 1,889.40 2,554.30 2,101.00 1,996.10 1,880.00 1,811.70 1,729.20 1,536.30 1,224.30 1,015.40 Power & Fuel Cost - 193.30 152.40 161.00 145.60 155.10 165.20 161.50 142.40 97.70 81.60 % Of Sales - 8.85% 5.27% 6.66% 5.63% 6.74% 7.37% 7.33% 7.35% 6.28% 5.23% Employee Cost - 344.80 289.10 408.60 365.00 321.90 284.40 266.40 227.60 191.60 145.60 % Of Sales - 15.79% 9.99% 16.89% 14.10% 13.98% 12.69% 12.10% 11.74% 12.32% 9.33% Manufacturing Exp. - 224.90 217.50 292.50 221.20 202.10 195.90 127.80 115.00 67.40 42.90 % Of Sales - 10.30% 7.52% 12.09% 8.55% 8.78% 8.74% 5.80% 5.93% 4.33% 2.75% General & Admin Exp. - 256.00 1,055.80 95.70 88.70 103.70 95.80 92.80 82.30 69.00 55.00 % Of Sales - 11.72% 36.49% 3.96% 3.43% 4.51% 4.27% 4.21% 4.25% 4.44% 3.52% Selling & Distn. Exp. - 29.90 31.90 70.10 96.40 96.00 94.80 109.60 93.30 84.90 59.40 % Of Sales - 1.37% 1.10% 2.90% 3.73% 4.17% 4.23% 4.98% 4.81% 5.46% 3.81% Miscellaneous Exp. - 12.80 19.10 23.70 44.00 13.70 28.50 20.20 13.20 9.30 59.40 % Of Sales - 0.59% 0.66% 0.98% 1.70% 0.60% 1.27% 0.92% 0.68% 0.60% 0.55% EBITDA 325.00 294.80 339.00 318.20 591.80 421.80 429.90 473.30 401.70 331.50 545.70 EBITDA Margin 15.74% 13.50% 11.72% 13.15% 22.87% 18.32% 19.18% 21.49% 20.73% 21.31% 34.96% Other Income 192.80 204.60 109.30 124.70 98.80 173.10 149.10 60.60 55.50 68.60 62.70 Interest 0.50 1.20 2.60 1.00 3.80 1.90 0.80 0.90 1.20 1.70 1.00 Depreciation 102.00 98.00 92.30 136.10 150.60 139.70 128.10 124.40 95.10 94.00 90.20 PBT 493.00 400.20 353.40 305.80 536.20 453.30 450.10 408.60 360.90 304.40 517.20 Tax 98.90 119.00 59.40 67.30 16.90 190.80 67.10 84.20 71.30 48.90 57.90 Tax Rate 20.06% 21.25% 10.76% 22.01% 3.15% 34.11% 15.67% 20.61% 20.55% 16.06% 11.19% PAT 394.10 440.90 492.70 238.50 519.30 368.60 361.20 324.40 275.70 255.50 459.30 PAT before Minority Interest 394.10 440.90 492.70 238.50 519.30 368.60 361.20 324.40 275.70 255.50 459.30 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 19.09% 20.19% 17.03% 9.86% 20.07% 16.01% 16.11% 14.73% 14.23% 16.42% 29.42% PAT Growth 32.52% -10.51% 106.58% -54.07% 40.88% 2.05% 11.34% 17.66% 7.91% -44.37% Unadjusted EPS 3.28 3.67 4.11 1.99 4.33 3.07 3.01 2.70 2.30 2.13 3.83

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

2,064.40

2,184.20

2,893.30

2,419.20

2,587.90

2,301.80

2,241.60

2,202.50

1,938.00

1,555.80

1,561.10

Net Sales Growth

8.03%

-24.51%

19.60%

-6.52%

12.43%

2.69%

1.78%

13.65%

24.57%

-0.34%

Cost Of Goods Sold

919.17

827.70

788.50

1,049.40

1,035.20

987.50

947.10

950.90

862.50

704.40

622.30

Gross Profit

1,145.23

1,356.50

2,104.80

1,369.80

1,552.70

1,314.30

1,294.50

1,251.60

1,075.50

851.40

938.80

GP Margin

55.48%

62.11%

72.75%

56.62%

60.00%

57.10%

57.75%

56.83%

55.50%

54.72%

60.14%

Total Expenditure

1,739.40

1,889.40

2,554.30

2,101.00

1,996.10

1,880.00

1,811.70

1,729.20

1,536.30

1,224.30

1,015.40

Power & Fuel Cost

193.30

152.40

161.00

145.60

155.10

165.20

161.50

142.40

97.70

81.60

% Of Sales

8.85%

5.27%

6.66%

5.63%

6.74%

7.37%

7.33%

7.35%

6.28%

5.23%

Employee Cost

344.80

289.10

408.60

365.00

321.90

284.40

266.40

227.60

191.60

145.60

% Of Sales

15.79%

9.99%

16.89%

14.10%

13.98%

12.69%

12.10%

11.74%

12.32%

9.33%

Manufacturing Exp.

224.90

217.50

292.50

221.20

202.10

195.90

127.80

115.00

67.40

42.90

% Of Sales

10.30%

7.52%

12.09%

8.55%

8.78%

8.74%

5.80%

5.93%

4.33%

2.75%

General & Admin Exp.

256.00

1,055.80

95.70

88.70

103.70

95.80

92.80

82.30

69.00

55.00

% Of Sales

11.72%

36.49%

3.96%

3.43%

4.51%

4.27%

4.21%

4.25%

4.44%

3.52%

Selling & Distn. Exp.

29.90

31.90

70.10

96.40

96.00

94.80

109.60

93.30

84.90

59.40

% Of Sales

1.37%

1.10%

2.90%

3.73%

4.17%

4.23%

4.98%

4.81%

5.46%

3.81%

Miscellaneous Exp.

12.80

19.10

23.70

44.00

13.70

28.50

20.20

13.20

9.30

59.40

% Of Sales

0.59%

0.66%

0.98%

1.70%

0.60%

1.27%

0.92%

0.68%

0.60%

0.55%

EBITDA

325.00

294.80

339.00

318.20

591.80

421.80

429.90

473.30

401.70

331.50

545.70

EBITDA Margin

15.74%

13.50%

11.72%

13.15%

22.87%

18.32%

19.18%

21.49%

20.73%

21.31%

34.96%

Other Income

192.80

204.60

109.30

124.70

98.80

173.10

149.10

60.60

55.50

68.60

62.70

Interest

0.50

1.20

2.60

1.00

3.80

1.90

0.80

0.90

1.20

1.70

1.00

Depreciation

102.00

98.00

92.30

136.10

150.60

139.70

128.10

124.40

95.10

94.00

90.20

PBT

493.00

400.20

353.40

305.80

536.20

453.30

450.10

408.60

360.90

304.40

517.20

Tax

98.90

119.00

59.40

67.30

16.90

190.80

67.10

84.20

71.30

48.90

57.90

Tax Rate

20.06%

21.25%

10.76%

22.01%

3.15%

34.11%

15.67%

20.61%

20.55%

16.06%

11.19%

PAT

394.10

440.90

492.70

238.50

519.30

368.60

361.20

324.40

275.70

255.50

459.30

PAT before Minority Interest

394.10

440.90

492.70

238.50

519.30

368.60

361.20

324.40

275.70

255.50

459.30

Minority Interest

0.00

PAT Margin

19.09%

20.19%

17.03%

9.86%

20.07%

16.01%

16.11%

14.73%

14.23%

16.42%

29.42%

PAT Growth

32.52%

-10.51%

106.58%

-54.07%

40.88%

2.05%

11.34%

17.66%

7.91%

-44.37%

Unadjusted EPS

3.28

3.67

4.11

1.99

4.33

3.07

3.01

2.70

2.30

2.13

3.83

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 6,745.20 6,367.20 5,514.40 4,123.40 3,891.10 3,347.40 3,089.80 2,877.30 2,485.30 2,086.50 1,806.00 Net Sales Growth 10.65% 15.46% 33.73% 5.97% 16.24% 8.34% 7.39% 15.77% 19.11% 15.53% Cost Of Goods Sold 6,294.40 2,052.20 1,896.60 1,636.10 1,446.60 1,290.40 1,255.60 1,186.10 1,044.40 852.00 725.40 Gross Profit 450.80 4,315.00 3,617.80 2,487.30 2,444.50 2,057.00 1,834.20 1,691.20 1,440.90 1,234.50 1,080.60 GP Margin 6.68% 67.77% 65.61% 60.32% 62.82% 61.45% 59.36% 58.78% 57.98% 59.17% 59.83% Total Expenditure 5,177.70 5,110.20 4,390.60 3,294.30 2,911.60 2,579.60 2,394.00 2,190.20 1,946.30 1,809.30 2,213.40 Power & Fuel Cost - 246.10 239.80 189.00 156.40 184.70 176.70 162.40 142.60 97.20 82.00 % Of Sales - 3.87% 4.35% 4.58% 4.02% 5.52% 5.72% 5.64% 5.74% 4.66% 4.54% Employee Cost - 1,458.80 1,165.30 931.10 747.00 610.10 533.40 466.30 389.40 307.60 238.80 % Of Sales - 22.91% 21.13% 22.58% 19.20% 18.23% 17.26% 16.21% 15.67% 14.74% 13.22% Manufacturing Exp. - 864.60 721.20 335.70 391.50 203.70 81.20 62.90 95.20 113.20 81.60 % Of Sales - 13.58% 13.08% 8.14% 10.06% 6.09% 2.63% 2.19% 3.83% 5.43% 4.52% General & Admin Exp. - 182.10 53.00 56.80 21.70 144.60 165.70 131.80 122.20 93.20 82.40 % Of Sales - 2.86% 0.96% 1.38% 0.56% 4.32% 5.36% 4.58% 4.92% 4.47% 4.56% Selling & Distn. Exp. - 270.30 277.50 98.20 107.40 100.80 108.70 118.90 99.60 89.40 62.40 % Of Sales - 4.25% 5.03% 2.38% 2.76% 3.01% 3.52% 4.13% 4.01% 4.28% 3.46% Miscellaneous Exp. - 36.10 37.20 47.40 41.00 45.30 72.70 61.80 52.90 256.70 62.40 % Of Sales - 0.57% 0.67% 1.15% 1.05% 1.35% 2.35% 2.15% 2.13% 12.30% 52.09% EBITDA 1,567.50 1,257.00 1,123.80 829.10 979.50 767.80 695.80 687.10 539.00 277.20 -407.40 EBITDA Margin 23.24% 19.74% 20.38% 20.11% 25.17% 22.94% 22.52% 23.88% 21.69% 13.29% -22.56% Other Income 132.70 507.50 414.30 206.20 157.10 79.20 53.10 55.90 56.70 309.40 1,035.50 Interest 53.50 64.90 70.90 61.50 26.00 29.30 8.90 1.70 8.10 12.40 24.30 Depreciation 640.90 552.20 447.80 385.10 277.20 248.70 221.00 203.60 179.30 175.80 156.70 PBT 1,005.80 1,147.40 1,019.40 588.70 833.40 569.00 519.00 537.70 408.30 398.40 447.10 Tax 233.00 315.10 212.30 156.90 161.60 142.20 95.70 106.90 97.50 55.90 72.10 Tax Rate 23.17% 25.94% 17.49% 26.65% 19.39% 19.49% 15.33% 19.88% 15.98% 14.03% 16.13% PAT 772.80 777.10 904.40 351.10 595.80 528.70 497.40 413.80 508.90 341.60 367.50 PAT before Minority Interest 700.80 899.80 1,001.70 431.80 671.80 587.40 528.40 430.80 512.70 342.50 375.00 Minority Interest -72.00 -122.70 -97.30 -80.70 -76.00 -58.70 -31.00 -17.00 -3.80 -0.90 -7.50 PAT Margin 11.46% 12.20% 16.40% 8.51% 15.31% 15.79% 16.10% 14.38% 20.48% 16.37% 20.35% PAT Growth -21.47% -14.08% 157.59% -41.07% 12.69% 6.29% 20.20% -18.69% 48.98% -7.05% Unadjusted EPS 6.44 6.48 7.54 2.93 4.97 4.41 4.15 3.45 4.24 2.85 3.06

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

6,745.20

6,367.20

5,514.40

4,123.40

3,891.10

3,347.40

3,089.80

2,877.30

2,485.30

2,086.50

1,806.00

Net Sales Growth

10.65%

15.46%

33.73%

5.97%

16.24%

8.34%

7.39%

15.77%

19.11%

15.53%

Cost Of Goods Sold

6,294.40

2,052.20

1,896.60

1,636.10

1,446.60

1,290.40

1,255.60

1,186.10

1,044.40

852.00

725.40

Gross Profit

450.80

4,315.00

3,617.80

2,487.30

2,444.50

2,057.00

1,834.20

1,691.20

1,440.90

1,234.50

1,080.60

GP Margin

6.68%

67.77%

65.61%

60.32%

62.82%

61.45%

59.36%

58.78%

57.98%

59.17%

59.83%

Total Expenditure

5,177.70

5,110.20

4,390.60

3,294.30

2,911.60

2,579.60

2,394.00

2,190.20

1,946.30

1,809.30

2,213.40

Power & Fuel Cost

246.10

239.80

189.00

156.40

184.70

176.70

162.40

142.60

97.20

82.00

% Of Sales

3.87%

4.35%

4.58%

4.02%

5.52%

5.72%

5.64%

5.74%

4.66%

4.54%

Employee Cost

1,458.80

1,165.30

931.10

747.00

610.10

533.40

466.30

389.40

307.60

238.80

% Of Sales

22.91%

21.13%

22.58%

19.20%

18.23%

17.26%

16.21%

15.67%

14.74%

13.22%

Manufacturing Exp.

864.60

721.20

335.70

391.50

203.70

81.20

62.90

95.20

113.20

81.60

% Of Sales

13.58%

13.08%

8.14%

10.06%

6.09%

2.63%

2.19%

3.83%

5.43%

4.52%

General & Admin Exp.

182.10

53.00

56.80

21.70

144.60

165.70

131.80

122.20

93.20

82.40

% Of Sales

2.86%

0.96%

1.38%

0.56%

4.32%

5.36%

4.58%

4.92%

4.47%

4.56%

Selling & Distn. Exp.

270.30

277.50

98.20

107.40

100.80

108.70

118.90

99.60

89.40

62.40

% Of Sales

4.25%

5.03%

2.38%

2.76%

3.01%

3.52%

4.13%

4.01%

4.28%

3.46%

Miscellaneous Exp.

36.10

37.20

47.40

41.00

45.30

72.70

61.80

52.90

256.70

62.40

% Of Sales

0.57%

0.67%

1.15%

1.05%

1.35%

2.35%

2.15%

2.13%

12.30%

52.09%

EBITDA

1,567.50

1,257.00

1,123.80

829.10

979.50

767.80

695.80

687.10

539.00

277.20

-407.40

EBITDA Margin

23.24%

19.74%

20.38%

20.11%

25.17%

22.94%

22.52%

23.88%

21.69%

13.29%

-22.56%

Other Income

132.70

507.50

414.30

206.20

157.10

79.20

53.10

55.90

56.70

309.40

1,035.50

Interest

53.50

64.90

70.90

61.50

26.00

29.30

8.90

1.70

8.10

12.40

24.30

Depreciation

640.90

552.20

447.80

385.10

277.20

248.70

221.00

203.60

179.30

175.80

156.70

PBT

1,005.80

1,147.40

1,019.40

588.70

833.40

569.00

519.00

537.70

408.30

398.40

447.10

Tax

233.00

315.10

212.30

156.90

161.60

142.20

95.70

106.90

97.50

55.90

72.10

Tax Rate

23.17%

25.94%

17.49%

26.65%

19.39%

19.49%

15.33%

19.88%

15.98%

14.03%

16.13%

PAT

772.80

777.10

904.40

351.10

595.80

528.70

497.40

413.80

508.90

341.60

367.50

PAT before Minority Interest

700.80

899.80

1,001.70

431.80

671.80

587.40

528.40

430.80

512.70

342.50

375.00

Minority Interest

-72.00

-122.70

-97.30

-80.70

-76.00

-58.70

-31.00

-17.00

-3.80

-0.90

-7.50

PAT Margin

11.46%

12.20%

16.40%

8.51%

15.31%

15.79%

16.10%

14.38%

20.48%

16.37%

20.35%

PAT Growth

-21.47%

-14.08%

157.59%

-41.07%

12.69%

6.29%

20.20%

-18.69%

48.98%

-7.05%

Unadjusted EPS

6.44

6.48

7.54

2.93

4.97

4.41

4.15

3.45

4.24

2.85

3.06

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 7,537.30 7,115.40 6,738.60 6,541.10 5,996.60 2,584.40 2,417.70 2,206.80 2,096.40 1,946.80 Share Capital 600.00 300.00 300.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 Total Reserves 6,853.80 6,756.00 6,389.00 6,397.10 5,896.60 2,458.40 2,203.10 2,004.00 1,903.80 1,764.50 Non-Current Liabilities -134.00 -70.20 54.50 117.20 238.90 184.60 197.00 178.50 160.30 175.90 Secured Loans -0.70 -0.70 64.40 128.50 125.10 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 1.40 2.10 2.80 3.90 11.40 11.40 25.90 40.00 60.50 65.80 Long Term Provisions 21.40 24.80 17.20 13.30 9.50 0.00 0.00 0.00 0.00 1.00 Current Liabilities 728.00 993.30 831.60 705.20 862.60 564.00 603.80 627.90 563.60 481.80 Trade Payables 521.20 643.90 579.70 450.50 394.40 300.80 268.50 265.00 251.10 199.70 Other Current Liabilities 97.60 214.30 146.30 145.00 141.30 60.30 89.90 67.90 76.90 57.10 Short Term Borrowings 0.00 0.00 0.00 0.00 225.50 56.10 81.50 77.30 86.80 96.30 Short Term Provisions 109.20 135.10 105.60 109.70 101.40 146.80 163.90 217.70 148.80 128.70 Total Liabilities 8,131.30 8,038.50 7,624.70 7,363.50 7,098.10 3,333.00 3,218.50 3,013.20 2,820.30 2,604.50 Net Block 720.70 1,059.20 858.80 894.10 893.80 914.30 949.30 851.40 685.00 679.60 Gross Block 1,884.70 2,526.50 2,181.90 2,081.70 1,934.30 1,832.10 1,730.00 1,457.80 1,212.70 1,117.30 Accumulated Depreciation 1,164.00 1,467.30 1,323.10 1,187.60 1,040.50 917.80 780.70 606.40 527.70 437.70 Non Current Assets 6,047.60 5,527.10 5,567.00 4,985.00 4,727.00 1,597.10 1,751.20 1,539.90 1,468.20 1,291.50 Capital Work in Progress 151.90 254.50 318.50 240.80 172.30 57.60 101.80 51.20 82.50 102.70 Non Current Investment 4,886.50 4,021.60 3,789.00 3,407.40 3,254.50 80.40 144.90 166.00 166.40 92.00 Long Term Loans & Adv. 280.90 180.70 558.70 402.60 371.70 425.50 313.10 355.20 530.70 417.20 Other Non Current Assets 7.60 11.10 42.00 40.10 34.70 119.30 242.10 116.10 3.60 0.00 Current Assets 2,083.70 2,511.40 2,057.70 2,378.50 2,371.10 1,735.90 1,467.30 1,473.30 1,352.10 1,313.00 Current Investments 138.80 113.40 453.80 524.70 598.30 84.30 348.30 453.00 490.60 393.90 Inventories 534.70 801.90 561.70 539.60 504.60 406.30 357.60 358.90 340.40 274.70 Sundry Debtors 573.20 901.80 739.90 798.20 503.80 555.10 494.60 427.00 445.00 418.10 Cash & Bank 375.30 356.00 196.90 382.90 643.00 621.20 204.20 179.20 40.00 210.30 Other Current Assets 461.70 159.10 89.10 118.70 121.40 69.00 62.60 55.20 36.10 16.00 Short Term Loans & Adv. 171.60 179.20 16.30 14.40 74.90 49.70 56.80 51.00 29.20 14.10 Net Current Assets 1,355.70 1,518.10 1,226.10 1,673.30 1,508.50 1,171.90 863.50 845.40 788.50 831.20 Total Assets 8,131.30 8,038.50 7,624.70 7,363.50 7,098.10 3,333.00 3,218.50 3,013.20 2,820.30 2,604.50

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

7,537.30

7,115.40

6,738.60

6,541.10

5,996.60

2,584.40

2,417.70

2,206.80

2,096.40

1,946.80

Share Capital

600.00

300.00

100.00

Total Reserves

6,853.80

6,756.00

6,389.00

6,397.10

5,896.60

2,458.40

2,203.10

2,004.00

1,903.80

1,764.50

Non-Current Liabilities

-134.00

-70.20

54.50

117.20

238.90

184.60

197.00

178.50

160.30

175.90

Secured Loans

-0.70

64.40

128.50

125.10

0.00

Unsecured Loans

1.40

2.10

2.80

3.90

11.40

25.90

40.00

60.50

65.80

Long Term Provisions

21.40

24.80

17.20

13.30

9.50

0.00

1.00

Current Liabilities

728.00

993.30

831.60

705.20

862.60

564.00

603.80

627.90

563.60

481.80

Trade Payables

521.20

643.90

579.70

450.50

394.40

300.80

268.50

265.00

251.10

199.70

Other Current Liabilities

97.60

214.30

146.30

145.00

141.30

60.30

89.90

67.90

76.90

57.10

Short Term Borrowings

0.00

225.50

56.10

81.50

77.30

86.80

96.30

Short Term Provisions

109.20

135.10

105.60

109.70

101.40

146.80

163.90

217.70

148.80

128.70

Total Liabilities

8,131.30

8,038.50

7,624.70

7,363.50

7,098.10

3,333.00

3,218.50

3,013.20

2,820.30

2,604.50

Net Block

720.70

1,059.20

858.80

894.10

893.80

914.30

949.30

851.40

685.00

679.60

Gross Block

1,884.70

2,526.50

2,181.90

2,081.70

1,934.30

1,832.10

1,730.00

1,457.80

1,212.70

1,117.30

Accumulated Depreciation

1,164.00

1,467.30

1,323.10

1,187.60

1,040.50

917.80

780.70

606.40

527.70

437.70

Non Current Assets

6,047.60

5,527.10

5,567.00

4,985.00

4,727.00

1,597.10

1,751.20

1,539.90

1,468.20

1,291.50

Capital Work in Progress

151.90

254.50

318.50

240.80

172.30

57.60

101.80

51.20

82.50

102.70

Non Current Investment

4,886.50

4,021.60

3,789.00

3,407.40

3,254.50

80.40

144.90

166.00

166.40

92.00

Long Term Loans & Adv.

280.90

180.70

558.70

402.60

371.70

425.50

313.10

355.20

530.70

417.20

Other Non Current Assets

7.60

11.10

42.00

40.10

34.70

119.30

242.10

116.10

3.60

0.00

Current Assets

2,083.70

2,511.40

2,057.70

2,378.50

2,371.10

1,735.90

1,467.30

1,473.30

1,352.10

1,313.00

Current Investments

138.80

113.40

453.80

524.70

598.30

84.30

348.30

453.00

490.60

393.90

Inventories

534.70

801.90

561.70

539.60

504.60

406.30

357.60

358.90

340.40

274.70

Sundry Debtors

573.20

901.80

739.90

798.20

503.80

555.10

494.60

427.00

445.00

418.10

Cash & Bank

375.30

356.00

196.90

382.90

643.00

621.20

204.20

179.20

40.00

210.30

Other Current Assets

461.70

159.10

89.10

118.70

121.40

69.00

62.60

55.20

36.10

16.00

Short Term Loans & Adv.

171.60

179.20

16.30

14.40

74.90

49.70

56.80

51.00

29.20

14.10

Net Current Assets

1,355.70

1,518.10

1,226.10

1,673.30

1,508.50

1,171.90

863.50

845.40

788.50

831.20

Total Assets

8,131.30

8,038.50

7,624.70

7,363.50

7,098.10

3,333.00

3,218.50

3,013.20

2,820.30

2,604.50

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 6,705.80 6,098.00 5,180.80 4,837.70 4,033.80 3,270.60 3,026.70 2,694.60 2,272.40 2,032.80 Share Capital 600.00 300.00 300.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 Total Reserves 5,997.00 5,720.80 4,812.30 4,670.20 3,933.80 3,132.70 2,806.20 2,491.80 2,079.80 1,850.50 Non-Current Liabilities 2,684.70 2,122.30 2,006.50 2,304.60 2,421.30 1,377.90 1,262.00 666.30 645.20 455.50 Secured Loans 1,220.80 1,523.50 1,787.00 2,104.30 2,061.00 758.20 580.40 124.00 9.30 0.00 Unsecured Loans 1.40 2.10 2.80 3.90 11.40 11.40 25.80 40.00 60.50 65.80 Long Term Provisions 85.80 66.10 49.30 36.00 29.90 15.00 7.80 4.00 0.00 1.00 Current Liabilities 4,008.00 3,038.50 2,141.30 1,678.30 1,665.70 1,554.70 1,379.60 989.90 1,015.80 1,060.60 Trade Payables 1,325.10 1,198.30 1,005.30 739.70 609.80 429.30 347.20 345.50 347.80 296.50 Other Current Liabilities 1,784.40 1,374.70 870.10 698.20 527.10 706.20 612.30 313.10 269.20 375.90 Short Term Borrowings 667.60 261.20 130.30 97.20 394.90 261.00 243.50 84.80 187.30 247.40 Short Term Provisions 230.90 204.30 135.60 143.20 133.90 158.20 176.60 246.50 211.50 140.80 Total Liabilities 14,075.80 11,867.70 9,796.30 9,196.70 8,386.60 6,375.40 5,750.60 4,416.10 3,937.20 3,586.60 Net Block 5,971.10 4,471.00 3,699.50 3,625.10 1,748.30 1,629.90 1,525.20 1,510.30 1,270.50 1,316.20 Gross Block 9,147.40 7,095.00 5,873.80 5,436.10 3,403.60 3,034.20 2,701.70 2,480.90 2,066.20 1,965.80 Accumulated Depreciation 3,176.30 2,624.00 2,174.30 1,811.00 1,655.30 1,404.30 1,176.50 970.60 795.70 649.60 Non Current Assets 8,750.80 6,979.20 5,647.70 5,149.00 4,415.70 3,812.80 3,111.80 2,176.10 1,937.50 1,779.40 Capital Work in Progress 2,196.00 1,898.90 1,302.80 839.20 2,239.50 1,676.40 1,205.60 312.50 389.50 262.10 Non Current Investment 108.50 182.50 63.80 188.80 26.80 0.00 64.50 64.50 64.20 60.90 Long Term Loans & Adv. 402.00 335.80 437.20 319.70 350.10 336.90 252.00 241.60 181.00 140.20 Other Non Current Assets 73.20 91.00 144.40 176.20 51.00 169.60 64.50 47.20 32.30 0.00 Current Assets 5,325.00 4,888.50 4,148.60 4,047.70 3,970.90 2,562.60 2,638.80 2,240.00 1,999.70 1,807.20 Current Investments 857.60 829.30 611.40 1,065.00 874.70 230.30 700.40 522.10 492.10 399.50 Inventories 1,435.90 1,031.60 722.50 635.30 542.40 452.70 376.60 398.40 378.30 413.70 Sundry Debtors 1,223.70 1,291.80 1,063.90 883.20 714.50 770.50 599.80 509.70 491.70 495.80 Cash & Bank 998.60 1,057.20 1,322.80 1,044.30 1,538.60 937.50 804.40 672.90 523.30 441.50 Other Current Assets 809.20 525.50 373.30 395.80 300.70 171.60 157.60 136.90 114.30 56.70 Short Term Loans & Adv. 265.60 153.10 54.70 24.10 227.10 75.80 81.80 81.40 37.10 20.20 Net Current Assets 1,317.00 1,850.00 2,007.30 2,369.40 2,305.20 1,007.90 1,259.20 1,250.10 983.90 746.60 Total Assets 14,075.80 11,867.70 9,796.30 9,196.70 8,386.60 6,375.40 5,750.60 4,416.10 3,937.20 3,586.60

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

6,705.80

6,098.00

5,180.80

4,837.70

4,033.80

3,270.60

3,026.70

2,694.60

2,272.40

2,032.80

Share Capital

600.00

300.00

100.00

Total Reserves

5,997.00

5,720.80

4,812.30

4,670.20

3,933.80

3,132.70

2,806.20

2,491.80

2,079.80

1,850.50

Non-Current Liabilities

2,684.70

2,122.30

2,006.50

2,304.60

2,421.30

1,377.90

1,262.00

666.30

645.20

455.50

Secured Loans

1,220.80

1,523.50

1,787.00

2,104.30

2,061.00

758.20

580.40

124.00

9.30

0.00

Unsecured Loans

1.40

2.10

2.80

3.90

11.40

25.80

40.00

60.50

65.80

Long Term Provisions

85.80

66.10

49.30

36.00

29.90

15.00

7.80

4.00

0.00

1.00

Current Liabilities

4,008.00

3,038.50

2,141.30

1,678.30

1,665.70

1,554.70

1,379.60

989.90

1,015.80

1,060.60

Trade Payables

1,325.10

1,198.30

1,005.30

739.70

609.80

429.30

347.20

345.50

347.80

296.50

Other Current Liabilities

1,784.40

1,374.70

870.10

698.20

527.10

706.20

612.30

313.10

269.20

375.90

Short Term Borrowings

667.60

261.20

130.30

97.20

394.90

261.00

243.50

84.80

187.30

247.40

Short Term Provisions

230.90

204.30

135.60

143.20

133.90

158.20

176.60

246.50

211.50

140.80

Total Liabilities

14,075.80

11,867.70

9,796.30

9,196.70

8,386.60

6,375.40

5,750.60

4,416.10

3,937.20

3,586.60

Net Block

5,971.10

4,471.00

3,699.50

3,625.10

1,748.30

1,629.90

1,525.20

1,510.30

1,270.50

1,316.20

Gross Block

9,147.40

7,095.00

5,873.80

5,436.10

3,403.60

3,034.20

2,701.70

2,480.90

2,066.20

1,965.80

Accumulated Depreciation

3,176.30

2,624.00

2,174.30

1,811.00

1,655.30

1,404.30

1,176.50

970.60

795.70

649.60

Non Current Assets

8,750.80

6,979.20

5,647.70

5,149.00

4,415.70

3,812.80

3,111.80

2,176.10

1,937.50

1,779.40

Capital Work in Progress

2,196.00

1,898.90

1,302.80

839.20

2,239.50

1,676.40

1,205.60

312.50

389.50

262.10

Non Current Investment

108.50

182.50

63.80

188.80

26.80

0.00

64.50

64.20

60.90

Long Term Loans & Adv.

402.00

335.80

437.20

319.70

350.10

336.90

252.00

241.60

181.00

140.20

Other Non Current Assets

73.20

91.00

144.40

176.20

51.00

169.60

64.50

47.20

32.30

0.00

Current Assets

5,325.00

4,888.50

4,148.60

4,047.70

3,970.90

2,562.60

2,638.80

2,240.00

1,999.70

1,807.20

Current Investments

857.60

829.30

611.40

1,065.00

874.70

230.30

700.40

522.10

492.10

399.50

Inventories

1,435.90

1,031.60

722.50

635.30

542.40

452.70

376.60

398.40

378.30

413.70

Sundry Debtors

1,223.70

1,291.80

1,063.90

883.20

714.50

770.50

599.80

509.70

491.70

495.80

Cash & Bank

998.60

1,057.20

1,322.80

1,044.30

1,538.60

937.50

804.40

672.90

523.30

441.50

Other Current Assets

809.20

525.50

373.30

395.80

300.70

171.60

157.60

136.90

114.30

56.70

Short Term Loans & Adv.

265.60

153.10

54.70

24.10

227.10

75.80

81.80

81.40

37.10

20.20

Net Current Assets

1,317.00

1,850.00

2,007.30

2,369.40

2,305.20

1,007.90

1,259.20

1,250.10

983.90

746.60

Total Assets

14,075.80

11,867.70

9,796.30

9,196.70

8,386.60

6,375.40

5,750.60

4,416.10

3,937.20

3,586.60

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 387.10 109.50 355.20 185.80 208.50 125.00 185.80 348.00 160.50 354.70 PBT 559.90 552.10 305.80 536.20 559.40 428.30 408.60 347.00 304.40 517.20 Adjustment -68.10 -111.80 64.90 110.80 -87.90 3.80 80.20 69.10 56.80 53.80 Changes in Working Capital -14.00 -193.90 72.20 -340.50 -57.80 -224.20 -210.00 2.90 -142.60 -165.40 Cash after chg. in Working capital 477.80 246.40 442.90 306.50 413.70 207.90 278.80 419.00 218.60 405.60 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -90.70 -136.90 -87.70 -120.70 -205.20 -82.90 -93.00 -71.00 -58.10 -50.90 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -212.90 310.90 -555.50 110.40 -321.10 146.20 46.10 -87.10 -196.20 -150.40 Net Fixed Assets 744.40 -280.60 -177.90 -215.90 -216.90 -57.90 -322.80 -213.80 -75.20 -134.97 Net Investments -890.30 107.80 -310.70 -79.30 -3,688.10 328.50 125.80 38.00 -171.10 -67.26 Others -67.00 483.70 -66.90 405.60 3,583.90 -124.40 243.10 88.70 50.10 51.83 Cash from Financing Activity -128.90 -208.20 -54.60 -238.30 73.00 -158.10 -187.00 -147.10 -111.30 -99.80 Net Cash Inflow / Outflow 45.30 212.20 -254.90 57.90 -39.60 113.10 44.90 113.80 -147.00 104.50 Opening Cash & Equivalents 305.70 89.10 341.60 290.10 321.90 204.00 154.00 39.80 185.30 77.10 Closing Cash & Equivalent 375.00 305.70 89.10 341.60 290.10 315.90 204.00 154.00 39.80 185.30

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

387.10

109.50

355.20

185.80

208.50

125.00

185.80

348.00

160.50

354.70

PBT

559.90

552.10

305.80

536.20

559.40

428.30

408.60

347.00

304.40

517.20

Adjustment

-68.10

-111.80

64.90

110.80

-87.90

3.80

80.20

69.10

56.80

53.80

Changes in Working Capital

-14.00

-193.90

72.20

-340.50

-57.80

-224.20

-210.00

2.90

-142.60

-165.40

Cash after chg. in Working capital

477.80

246.40

442.90

306.50

413.70

207.90

278.80

419.00

218.60

405.60

Interest Paid

0.00

Tax Paid

-90.70

-136.90

-87.70

-120.70

-205.20

-82.90

-93.00

-71.00

-58.10

-50.90

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

Cash From Investing Activity

-212.90

310.90

-555.50

110.40

-321.10

146.20

46.10

-87.10

-196.20

-150.40

Net Fixed Assets

744.40

-280.60

-177.90

-215.90

-216.90

-57.90

-322.80

-213.80

-75.20

-134.97

Net Investments

-890.30

107.80

-310.70

-79.30

-3,688.10

328.50

125.80

38.00

-171.10

-67.26

Others

-67.00

483.70

-66.90

405.60

3,583.90

-124.40

243.10

88.70

50.10

51.83

Cash from Financing Activity

-128.90

-208.20

-54.60

-238.30

73.00

-158.10

-187.00

-147.10

-111.30

-99.80

Net Cash Inflow / Outflow

45.30

212.20

-254.90

57.90

-39.60

113.10

44.90

113.80

-147.00

104.50

Opening Cash & Equivalents

305.70

89.10

341.60

290.10

321.90

204.00

154.00

39.80

185.30

77.10

Closing Cash & Equivalent

375.00

305.70

89.10

341.60

290.10

315.90

204.00

154.00

39.80

185.30

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 1,283.10 1,154.60 662.10 640.00 370.60 210.70 560.70 471.20 564.10 798.50 PBT 870.90 1,002.60 610.00 849.70 751.30 624.10 537.70 610.20 395.20 447.10 Adjustment 921.40 472.60 355.70 204.40 42.00 74.00 134.00 147.30 144.80 163.50 Changes in Working Capital -165.10 -29.10 -106.50 -211.10 -176.20 -354.00 37.70 -192.30 98.00 269.20 Cash after chg. in Working capital 1,627.20 1,446.10 859.20 843.00 617.10 344.10 709.40 565.20 638.00 879.80 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -344.10 -291.50 -197.10 -203.00 -246.50 -133.40 -148.70 -94.00 -73.90 -81.30 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1,558.90 -713.80 -684.00 -498.50 -1,141.70 -508.70 -938.10 -375.80 -359.50 -314.50 Net Fixed Assets 744.40 -280.60 -177.90 -215.90 -216.90 -57.90 -322.80 -213.80 -75.20 -134.97 Net Investments -890.30 107.80 -310.70 -79.30 -3,688.10 328.50 125.80 38.00 -171.10 -67.26 Others -1,413.00 -541.00 -195.40 -203.30 2,763.30 -779.30 -741.10 -200.00 -113.20 -112.27 Cash from Financing Activity 387.60 -241.70 -239.70 -177.50 1,067.60 186.20 426.00 -8.60 -186.30 -274.60 Net Cash Inflow / Outflow 111.80 199.10 -261.60 -36.00 296.50 -111.80 48.60 86.80 18.30 209.40 Opening Cash & Equivalents 659.30 449.00 710.20 757.50 457.50 557.00 474.00 369.00 359.00 139.90 Closing Cash & Equivalent 824.70 659.30 449.00 710.20 757.50 462.60 557.00 474.00 369.00 359.00

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

1,283.10

1,154.60

662.10

640.00

370.60

210.70

560.70

471.20

564.10

798.50

PBT

870.90

1,002.60

610.00

849.70

751.30

624.10

537.70

610.20

395.20

447.10

Adjustment

921.40

472.60

355.70

204.40

42.00

74.00

134.00

147.30

144.80

163.50

Changes in Working Capital

-165.10

-29.10

-106.50

-211.10

-176.20

-354.00

37.70

-192.30

98.00

269.20

Cash after chg. in Working capital

1,627.20

1,446.10

859.20

843.00

617.10

344.10

709.40

565.20

638.00

879.80

Interest Paid

0.00

Tax Paid

-344.10

-291.50

-197.10

-203.00

-246.50

-133.40

-148.70

-94.00

-73.90

-81.30

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

Cash From Investing Activity

-1,558.90

-713.80

-684.00

-498.50

-1,141.70

-508.70

-938.10

-375.80

-359.50

-314.50

Net Fixed Assets

744.40

-280.60

-177.90

-215.90

-216.90

-57.90

-322.80

-213.80

-75.20

-134.97

Net Investments

-890.30

107.80

-310.70

-79.30

-3,688.10

328.50

125.80

38.00

-171.10

-67.26

Others

-1,413.00

-541.00

-195.40

-203.30

2,763.30

-779.30

-741.10

-200.00

-113.20

-112.27

Cash from Financing Activity

387.60

-241.70

-239.70

-177.50

1,067.60

186.20

426.00

-8.60

-186.30

-274.60

Net Cash Inflow / Outflow

111.80

199.10

-261.60

-36.00

296.50

-111.80

48.60

86.80

18.30

209.40

Opening Cash & Equivalents

659.30

449.00

710.20

757.50

457.50

557.00

474.00

369.00

359.00

139.90

Closing Cash & Equivalent

824.70

659.30

449.00

710.20

757.50

462.60

557.00

474.00

369.00

359.00

Financial Ratios

Consolidated /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 62.11 58.79 55.73 54.13 49.96 21.31 19.18 17.53 16.69 15.53 ROA 5.45% 6.29% 3.18% 7.18% 7.07% 11.03% 10.41% 9.45% 9.42% 18.86% ROE 6.08% 7.17% 3.62% 8.31% 8.62% 14.87% 14.73% 13.43% 13.22% 27.28% ROCE 7.62% 7.89% 4.53% 8.28% 12.43% 16.49% 16.80% 15.16% 14.01% 26.77% Fixed Asset Turnover 0.99 1.23 1.14 1.30 1.24 1.28 1.40 1.49 1.38 1.49 Receivable days 123.24 103.55 115.73 90.75 82.75 84.24 75.11 80.24 98.12 91.42 Inventory Days 111.68 86.01 82.86 72.78 71.18 61.30 58.39 64.35 69.93 59.24 Payable days 116.98 136.16 88.11 78.17 66.14 55.67 54.21 61.84 64.42 65.62 Cash Conversion Cycle 117.94 53.40 110.48 85.36 87.79 89.87 79.29 82.75 103.64 85.04 Total Debt/Equity 0.00 0.01 0.02 0.02 0.06 0.03 0.05 0.06 0.08 0.09 Interest Cover 467.58 213.35 306.80 142.11 295.42 536.38 455.00 290.17 180.06 518.20

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

62.11

58.79

55.73

54.13

49.96

21.31

19.18

17.53

16.69

15.53

ROA

5.45%

6.29%

3.18%

7.18%

7.07%

11.03%

10.41%

9.45%

9.42%

18.86%

ROE

6.08%

7.17%

3.62%

8.31%

8.62%

14.87%

14.73%

13.43%

13.22%

27.28%

ROCE

7.62%

7.89%

4.53%

8.28%

12.43%

16.49%

16.80%

15.16%

14.01%

26.77%

Fixed Asset Turnover

0.99

1.23

1.14

1.30

1.24

1.28

1.40

1.49

1.38

1.49

Receivable days

123.24

103.55

115.73

90.75

82.75

84.24

75.11

80.24

98.12

91.42

Inventory Days

111.68

86.01

82.86

72.78

71.18

61.30

58.39

64.35

69.93

59.24

Payable days

116.98

136.16

88.11

78.17

66.14

55.67

54.21

61.84

64.42

65.62

Cash Conversion Cycle

117.94

53.40

110.48

85.36

87.79

89.87

79.29

82.75

103.64

85.04

Total Debt/Equity

0.00

0.01

0.02

0.06

0.03

0.05

0.06

0.08

0.09

Interest Cover

467.58

213.35

306.80

142.11

295.42

536.38

455.00

290.17

180.06

518.20

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 54.97 50.17 42.59 39.74 33.61 26.93 24.21 21.59 18.16 16.25 ROA 6.94% 9.25% 4.55% 7.64% 7.96% 8.72% 8.47% 12.28% 9.10% 11.50% ROE 14.26% 18.00% 8.74% 15.26% 16.17% 17.22% 15.68% 21.50% 16.59% 20.58% ROCE 14.35% 16.11% 8.92% 12.59% 13.93% 15.30% 15.75% 22.47% 16.74% 20.33% Fixed Asset Turnover 0.78 0.85 0.73 0.89 1.05 1.09 1.12 1.11 1.06 0.97 Receivable days 72.10 77.96 86.05 74.35 80.16 80.09 69.48 72.22 84.37 93.20 Inventory Days 70.72 58.05 60.00 54.81 53.71 48.47 48.54 56.01 67.67 77.71 Payable days 80.65 81.98 87.98 78.68 71.28 58.15 55.73 65.24 70.25 70.62 Cash Conversion Cycle 62.18 54.04 58.07 50.48 62.59 70.42 62.29 62.99 81.79 100.29 Total Debt/Equity 0.40 0.40 0.44 0.48 0.61 0.35 0.30 0.10 0.12 0.17 Interest Cover 19.72 18.12 10.57 33.05 25.90 71.12 317.29 76.33 33.13 19.40

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

54.97

50.17

42.59

39.74

33.61

26.93

24.21

21.59

18.16

16.25

ROA

6.94%

9.25%

4.55%

7.64%

7.96%

8.72%

8.47%

12.28%

9.10%

11.50%

ROE

14.26%

18.00%

8.74%

15.26%

16.17%

17.22%

15.68%

21.50%

16.59%

20.58%

ROCE

14.35%

16.11%

8.92%

12.59%

13.93%

15.30%

15.75%

22.47%

16.74%

20.33%

Fixed Asset Turnover

0.78

0.85

0.73

0.89

1.05

1.09

1.12

1.11

1.06

0.97

Receivable days

72.10

77.96

86.05

74.35

80.16

80.09

69.48

72.22

84.37

93.20

Inventory Days

70.72

58.05

60.00

54.81

53.71

48.47

48.54

56.01

67.67

77.71

Payable days

80.65

81.98

87.98

78.68

71.28

58.15

55.73

65.24

70.25

70.62

Cash Conversion Cycle

62.18

54.04

58.07

50.48

62.59

70.42

62.29

62.99

81.79

100.29

Total Debt/Equity

0.40

0.44

0.48

0.61

0.35

0.30

0.10

0.12

0.17

Interest Cover

19.72

18.12

10.57

33.05

25.90

71.12

317.29

76.33

33.13

19.40

Annual Reports:

News Update

Biocon’s arm receives Rs 555 crore capital injection from ADQ
8th Jan 2021, 09:08 AM

Post the completion of this transaction, Biocon will hold 89.89% stake in Biocon Biologics on a fully diluted basis
Read More
Biocon launches Tacrolimus capsules in US
28th Dec 2020, 16:51 PM

The launch of Tacrolimus capsules in the US is another milestone for Biocon that reflects commitment to continually evaluate and expand portfolio of complex products to serve patients
Read More
Biocon’s arm signs MoU with CSSC for Mission 10 cents
16th Dec 2020, 08:52 AM

Tanzania will be the first country in Africa that will benefit from this collaboration between Biocon Biologics and CSSC
Read More
Biocon’s arm raises Rs 1125 crore through OCDs
10th Dec 2020, 11:22 AM

The company has allotted 1,125 OCDs having face value of Rs 1 crore each
Read More
Biocon enters into agreement to acquire stake in HRTPL
23rd Nov 2020, 15:55 PM

HRTPL was incorporated on September 25, 2020, which will engage in the business of power generation
Read More
Biocon’s arm receives Rs 1,125 crore capital injection from Goldman Sachs
9th Nov 2020, 08:52 AM

Goldman Sachs will be issued Optionally Convertible Debentures at a post money equity valuation of $3.94 billion
Read More
Biocon ranked among top 5 biotech employers globally
30th Oct 2020, 12:17 PM

Ranked at No. 5 among global pharma and biotech companies in 2020, Biocon has moved up steadily from No. 7 in 2018 and No. 6 in 2019
Read More
Biocon reports 23% fall in Q2 consolidated net profit
23rd Oct 2020, 10:32 AM

Total income of the company increased by 9.63% at Rs 1760.30 crore for Q2FY21
Read More
Biocon - Quarterly Results
22nd Oct 2020, 23:53 PM

Read More
Biocon’s CSR arm signs MoU with BMRCL
9th Oct 2020, 09:58 AM

MoU aims to contribute Rs 65 crore towards funding the construction of the proposed Hebbagodi Metro Station on Hosur Road
Read More

Biocon Ltd.

Pharmaceuticals & Drugs - Global

BSE: 532523 | NSE: BIOCON

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update